SPYRE THERAPEUTICS, INC. (SYRE) Net margin 2016–2023
SPYRE THERAPEUTICS, INC. (SYRE) net profit margin by fiscal year — reported net income divided by reported revenue.
-38238.1%FY2023 · since FY2016: -468.8% → -38238.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -38238.1% | -34639.4 pp |
| FY2022 | -3598.8% | -3247.6 pp |
| FY2021 | -351.1% | — |
| FY2018 | -1140.6% | -617.4 pp |
| FY2017 | -523.3% | -54.4 pp |
| FY2016 | -468.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice